Status:
COMPLETED
BRITEPath- Phase 2
Lead Sponsor:
University of Pittsburgh
Collaborating Sponsors:
Kaiser Foundation Research Institute
National Institute of Mental Health (NIMH)
Conditions:
Depression
Suicidal Ideation
Eligibility:
All Genders
12-26 years
Phase:
NA
Brief Summary
BRITEPath (BP) aims to support co-located mental health clinicians in the development of a high quality, effective, and personalized safety plan for referred patients who screen positive for depressio...
Detailed Description
BRITEPath has 3 components: 1) BRITE, an emotion regulation and safety planning phone app that is delivered by a co-located mental health (MH) clinician to adolescents at the time of their first thera...
Eligibility Criteria
Inclusion
- Youth aged 12-26yo
- Own a device (e.g. smartphone, iPod, tablet) with capability to download BRITE app
- Biological or adoptive parent is willing to provide informed consent for teen to participate
- Youth speaks and understands English
- Positive PHQ score or provider determines youth has depressive symptoms based on clinical interaction and refers youth to the study (in cases when PHQ is not available and study staff will complete the PHQ during the screening) OR Provider can refer if they are unclear if symptoms are depressive and PHQ scoring will be used to determine youth's eligibility. OR Screening Wizard screening questionnaire (which includes the PHQ and depressive symptom questions) indicates depression OR provider/parent have concern that youth/patient has a mood or behavioral problem
- Family agrees to see an (embedded) MH therapist at the practice
- PHQ scores: Score of 8 or higher on PHQ-8 -or- Score of 1 or higher on #9 of PHQ-9 suicidality item
Exclusion
- Non English speaking
- No parent willing to provide informed consent
- No cell phone capability of downloading BRITE app
- Is currently experiencing mania or psychosis
- Evidence of an intellectual or developmental disorder (IDD)
- Life threatening medical condition that requires immediate treatment (including emergent suicidality, homicidally, abuse/neglect, or other mental or physical condition)
- Other cognitive or medical condition preventing youth from understanding study and/or participating.
- Currently receiving MH treatment/currently satisfied with treatment
Key Trial Info
Start Date :
November 5 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 31 2022
Estimated Enrollment :
101 Patients enrolled
Trial Details
Trial ID
NCT04672798
Start Date
November 5 2020
End Date
July 31 2022
Last Update
June 5 2023
Active Locations (6)
Enter a location and click search to find clinical trials sorted by distance.
1
Henry Ford Health System
Detroit, Michigan, United States, 48126
2
Northwell Hospital
Hyde Park, New York, United States, 11040
3
Children's Community Pediatrics (CCP-Moon) of Children's Hospital of Pittsburgh of UPMC
Moon Township, Pennsylvania, United States, 15108
4
STAR- Center
Pittsburgh, Pennsylvania, United States, 15213